Maria Diez-Campelo

Maria Diez-Campelo

UNVERIFIED PROFILE

Are you Maria Diez-Campelo?   Register this Author

Register author
Maria Diez-Campelo

Maria Diez-Campelo

Publications by authors named "Maria Diez-Campelo"

Are you Maria Diez-Campelo?   Register this Author

57Publications

2417Reads

31Profile Views

SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia.

J Exp Clin Cancer Res 2019 Feb 14;38(1):80. Epub 2019 Feb 14.

Department of Biochemistry and Molecular Biology, University of Salamanca, Edificio Departamental, Lab 122, Plaza Doctores de la Reina, S/N, P.O. 37007, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-019-1097-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376690PMC
February 2019

Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability.

Biol Blood Marrow Transplant 2018 03 16;24(3):443-451. Epub 2017 Nov 16.

Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Salamanca, Spain; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Spain; Universidad de Salamanca, Salamanca, Spain; RETIC TerCel, ISCIII, Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.11.007DOI Listing
March 2018

A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.

Leuk Res 2017 05 4;56:82-87. Epub 2017 Feb 4.

IBMCC, Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Spain; Hospital Universitario de Salamanca, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.01.031DOI Listing
May 2017

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

J Clin Oncol 2016 09 5;34(27):3284-92. Epub 2016 Jul 5.

Leonor Arenillas, Xavier Calvo, Carme Pedro, Ana Ferrer, and Lourdes Florensa, Hospital del Mar Research Institute; Esther Alonso, Hospital Universitario Bellvitge Hospitalet de Llobregat; Julia Montoro, Hospital Universitario Vall d' Hebron; Salut Brunet, Hospital Santa Creu i Sant Pau; Benet Nomdedeu, Hospital Clínic, Barcelona; Elisa Luño, Hospital Universitario Central Asturias, Oviedo; Leonor Senent and Guillermo F. Sanz, Hospital Universitario La Fe; Mar Tormo, Hospital Clínico Universitario de Valencia; Rafael Andreu, Hospital Universitario Doctor Peset, Valencia; Fernando Ramos, Hospital Universitario de León, León; María Teresa Ardanaz, Hospital Universitario Txagorritxu, Vitoria; Víctor Marco, Hospital Arnau Vilanova, Lleida; María Díez-Campelo, Hospital Universitario de Salamanca, Salamanca; Beatriz Arrizabalaga, Hospital Universitario Cruces, Baracaldo; Blanca Xicoy, ICO-Badalona, Badalona; Santiago Bonanad, Hospital La Ribera, Alzira; and Andrés Jerez, Hospital Morales Meseguer, IMIB-Arrixaca, Murcia, Spain.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.66.9705
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.66.9705DOI Listing
September 2016

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow.

Stem Cell Res Ther 2015 Sep 7;6:169. Epub 2015 Sep 7.

Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca (USAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13287-015-0152-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562124PMC
September 2015

Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Oct 19;20(10):1580-5. Epub 2014 Jun 19.

Servicio de Hematología, Instituto de biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.06.015DOI Listing
October 2014

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.

J Allergy Clin Immunol 2013 Apr 10;131(4):1213-24, 1224.e1-4. Epub 2013 Feb 10.

Servicio General de Citometría, Centro de Investigación del Cáncer (IBMCC-CSIC/USAL and IBSAL) and Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2012.12.674DOI Listing
April 2013

Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation.

Transfusion 2012 May 24;52(5):1086-91. Epub 2011 Oct 24.

Servicio de Hematología, Hospital Universitario de Salamanca; the Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León; and the Centro de Investigación del Cáncer-IBMCC (Universidad de Salamanca-CSIC), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2011.03400.xDOI Listing
May 2012

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

Haematologica 2011 Jul 10;96(7):1072-6. Epub 2011 Mar 10.

Servicio de Hematología, Instituto de Biomedicina de Sevilla (IBIS) Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Avenida Manuel Siurot s/n 41013 Sevilla, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.038356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128230PMC
July 2011

Azacytidine for the treatment of myelodysplastic syndromes in the elderly.

Adv Ther 2011 Mar 9;28 Suppl 2:10-5. Epub 2011 Mar 9.

Department of Hematology, Hospital Universitario, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-010-0097-3DOI Listing
March 2011

Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.

Transfusion 2009 Sep 20;49(9):1901-10. Epub 2009 May 20.

Hematology, Cell Therapy Area and Immunology Service, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2009.02226.xDOI Listing
September 2009

Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells.

J Immunol 2009 Jan;182(1):92-101

Department of Hematology, Laboratory of Experimental Hematology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.182.1.92DOI Listing
January 2009

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.

Haematologica 2008 Sep 18;93(9):1301-9. Epub 2008 Jul 18.

Servicio de Hematología, Hospital Clínico Universitario y CIC, Paseo de San Vicente s/n, 37007, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.12857DOI Listing
September 2008

Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease.

Expert Opin Investig Drugs 2008 Sep;17(9):1389-401

Hospital Universitario de Salamanca, Servicio de Hematología, Paseo de San Vicente 58-182, 37007 Salamanca, Spain.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.17.9.13
Publisher Site
http://dx.doi.org/10.1517/13543784.17.9.1389DOI Listing
September 2008